The current study was conducted on 61 specimens of GBM patients aimed to evaluate PD-L1 &LC3B expression in glioblastoma besides their correlation with different clinicopathologic parameters, and the relationship between their expressions and to assess the effect of PD-L1 &LC3B expression on survival analysis of patients with GBM. The gene discussed is MAP1LC3B; the disease is glioblastoma.